TreeWAS – Variant ID: rs2954031

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E78.0 Pure hypercholesterolaemia	0.000	0.000	1.000
I25.1 Atherosclerotic heart disease	0.000	0.000	1.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.000	0.000	1.000
E78.5 Hyperlipidaemia, unspecified	0.000	0.002	0.998
I25 Chronic ischaemic heart disease	0.000	0.009	0.991
E78.2 Mixed hyperlipidaemia	0.000	0.020	0.980
I25.8 Other forms of chronic ischaemic heart disease	0.000	0.027	0.973
I25.3 Aneurysm of heart	0.000	0.077	0.923
K76.0 Fatty (change of) liver, not elsewhere classified	0.000	0.085	0.915
I25.0 Atherosclerotic cardiovascular disease, so described	0.000	0.144	0.856
E78.1 Pure hyperglyceridaemia	0.000	0.148	0.852
E78.8 Other disorders of lipoprotein metabolism	0.000	0.185	0.815
E78.4 Other hyperlipidaemia	0.000	0.205	0.795
I25.4 Coronary artery aneurysm	0.000	0.208	0.792
E78.9 Disorder of lipoprotein metabolism, unspecified	0.000	0.249	0.751
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.251	0.749
E78.6 Lipoprotein deficiency	0.000	0.326	0.674
I25.6 Silent myocardial ischaemia	0.000	0.332	0.667
E78.3 Hyperchylomicronaemia	0.000	0.352	0.648
I25.5 Ischaemic cardiomyopathy	0.000	0.382	0.618
I25.2 Old myocardial infarction	0.000	0.400	0.600
I20-I25 Ischaemic heart diseases	0.000	0.698	0.302
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.703	0.297
I21 Acute myocardial infarction	0.000	0.705	0.295
K76 Other diseases of liver	0.000	0.709	0.291
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.722	0.278
K76.6 Portal hypertension	0.000	0.743	0.257
I23 Certain current complications following acute myocardial infarction	0.000	0.767	0.233
K76.7 Hepatorenal syndrome	0.000	0.769	0.231
I21.X Presumed acute myicardial infaction (unconfirmed)	0.000	0.789	0.211
K76.5 Hepatic veno-occlusive disease	0.000	0.791	0.209
K76.4 Peliosis hepatis	0.000	0.791	0.209
K76.3 Infarction of liver	0.000	0.791	0.209
K76.2 Central haemorrhagic necrosis of liver	0.000	0.791	0.209
I21.4 Acute subendocardial myocardial infarction	0.000	0.808	0.192
I23.8 Other current complications following acute myocardial infarction	0.000	0.817	0.183
K76.1 Chronic passive congestion of liver	0.000	0.821	0.179
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.000	0.833	0.167
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.000	0.833	0.167
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.000	0.833	0.167
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.000	0.833	0.167
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.000	0.833	0.167
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.000	0.833	0.167
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.000	0.833	0.167
K76.9 Liver disease, unspecified	0.000	0.840	0.160
I21.3 Acute transmural myocardial infarction of unspecified site	0.000	0.852	0.148
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.891	0.109
I22 Subsequent myocardial infarction	0.000	0.899	0.101
I24 Other acute ischaemic heart diseases	0.000	0.917	0.083
I21.9 Acute myocardial infarction, unspecified	0.000	0.919	0.081
I22.0 Subsequent myocardial infarction of anterior wall	0.000	0.927	0.073
K76.8 Other specified diseases of liver	0.000	0.932	0.068
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.938	0.062
I24.1 Dressler's syndrome	0.000	0.940	0.060
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.948	0.052
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.051	0.949	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.050	0.950	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.049	0.951	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.049	0.951	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.049	0.951	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.048	0.952	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.048	0.952	0.000
I50.1 Left ventricular failure	0.000	0.955	0.045
T43.0 Tricyclic and tetracyclic antidepressants	0.044	0.956	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.044	0.956	0.000
T39.0 Salicylates	0.044	0.956	0.000
T43.2 Other and unspecified antidepressants	0.044	0.956	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.043	0.957	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.042	0.958	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.042	0.958	0.000
T50.8 Diagnostic agents	0.041	0.959	0.000
I24.8 Other forms of acute ischaemic heart disease	0.000	0.960	0.040
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.961	0.039
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.038	0.962	0.000
T50.1 Loop [high-ceiling] diuretics	0.038	0.962	0.000
B34.9 Viral infection, unspecified	0.000	0.962	0.038
I22.8 Subsequent myocardial infarction of other sites	0.000	0.963	0.037
T50.4 Drugs affecting uric acid metabolism	0.037	0.963	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.036	0.964	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.036	0.964	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.036	0.964	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.036	0.964	0.000
T43.6 Psychostimulants with abuse potential	0.036	0.964	0.000
T50.7 Analeptics and opioid receptor antagonists	0.036	0.964	0.000
T50.5 Appetite depressants	0.036	0.964	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.036	0.964	0.000
T50.0 Mineralocorticoids and their antagonists	0.036	0.964	0.000
T39.4 Antirheumatics, not elsewhere classified	0.036	0.964	0.000
T39.2 Pyrazolone derivatives	0.036	0.964	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.036	0.964	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.035	0.964	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.035	0.965	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.035	0.965	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.035	0.965	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.035	0.965	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.035	0.965	0.000
T44.0 Anticholinesterase agents	0.035	0.965	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.035	0.965	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.965	0.035
E10.3 With ophthalmic complications	0.035	0.965	0.000
K70-K77 Diseases of liver	0.000	0.965	0.035
T43.8 Other psychotropic drugs, not elsewhere classified	0.035	0.965	0.000
I20 Angina pectoris	0.000	0.966	0.034
T43.9 Psychotropic drug, unspecified	0.034	0.966	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.034	0.966	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.034	0.966	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.033	0.966	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.033	0.967	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.031	0.969	0.000
T36 Poisoning by systemic antibiotics	0.031	0.969	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.031	0.969	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.030	0.970	0.000
T37.5 Antiviral drugs	0.030	0.970	0.000
T37.4 Anthelminthics	0.030	0.970	0.000
T37.3 Other antiprotozoal drugs	0.030	0.970	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.030	0.970	0.000
T37.1 Antimycobacterial drugs	0.030	0.970	0.000
T37.0 Sulphonamides	0.030	0.970	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.030	0.970	0.000
I35.2 Aortic (valve) stenosis with insufficiency	0.000	0.970	0.030
T43.5 Other and unspecified antipsychotics and neuroleptics	0.030	0.970	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.029	0.971	0.000
B34 Viral infection of unspecified site	0.000	0.971	0.029
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.028	0.972	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.028	0.972	0.000
E10 Insulin-dependent diabetes mellitus	0.028	0.972	0.000
K73 Chronic hepatitis, not elsewhere classified	0.000	0.972	0.028
T38.1 Thyroid hormones and substitutes	0.027	0.972	0.000
T49.9 Topical agent, unspecified	0.027	0.973	0.000
T49.8 Other topical agents	0.027	0.973	0.000
T49.7 Dental drugs, topically applied	0.027	0.973	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.027	0.973	0.000
T49.5 Ophthalmological drugs and preparations	0.027	0.973	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.027	0.973	0.000
T49.3 Emollients, demulcents and protectants	0.027	0.973	0.000
T49.2 Local astringents and local detergents	0.027	0.973	0.000
T49.1 Antipruritics	0.027	0.973	0.000
T47.6 Antidiarrhoeal drugs	0.027	0.973	0.000
K71 Toxic liver disease	0.000	0.973	0.027
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.027	0.973	0.000
E10.4 With neurological complications	0.026	0.974	0.000
T41.5 Therapeutic gases	0.026	0.974	0.000
T41.4 Anaesthetic, unspecified	0.026	0.974	0.000
T41.3 Local anaesthetics	0.026	0.974	0.000
T41.2 Other and unspecified general anaesthetics	0.026	0.974	0.000
T41.1 Intravenous anaesthetics	0.026	0.974	0.000
T41.0 Inhaled anaesthetics	0.026	0.974	0.000
T38.9 Other and unspecified hormone antagonists	0.026	0.974	0.000
T38.7 Androgens and anabolic congeners	0.026	0.974	0.000
T38.5 Other oestrogens and progestogens	0.026	0.974	0.000
T38.4 Oral contraceptives	0.026	0.974	0.000
T38.2 Antithyroid drugs	0.026	0.974	0.000
T38.0 Glucocorticoids and synthetic analogues	0.026	0.974	0.000
T45.2 Vitamins, not elsewhere classified	0.026	0.974	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.026	0.974	0.000
B34.4 Papovirus infection, unspecified	0.000	0.974	0.026
T38.8 Other and unspecified hormones and their synthetic substitutes	0.026	0.974	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.026	0.974	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.026	0.974	0.000
T47.7 Emetics	0.026	0.974	0.000
T47.5 Digestants	0.026	0.974	0.000
T47.3 Saline and osmotic laxatives	0.026	0.974	0.000
T47.2 Stimulant laxatives	0.026	0.974	0.000
K77 Liver disorders in diseases classified elsewhere	0.000	0.975	0.025
T47.0 Histamine H(2)-receptor antagonists	0.024	0.976	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.024	0.976	0.000
T48.4 Expectorants	0.024	0.976	0.000
T48.3 Antitussives	0.024	0.976	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.024	0.976	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.024	0.976	0.000
T48.0 Oxytocic drugs	0.024	0.976	0.000
T47.4 Other laxatives	0.024	0.976	0.000
T42.1 Iminostilbenes	0.024	0.976	0.000
B34.8 Other viral infections of unspecified site	0.000	0.976	0.024
T40.6 Other and unspecified narcotics	0.024	0.976	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.024	0.976	0.000
T45.8 Other primarily systemic and haematological agents	0.024	0.976	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.024	0.976	0.000
T45.6 Fibrinolysis-affecting drugs	0.024	0.976	0.000
T45.4 Iron and its compounds	0.024	0.976	0.000
T45.3 Enzymes, not elsewhere classified	0.024	0.976	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.024	0.976	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.023	0.976	0.000
T45.5 Anticoagulants	0.024	0.976	0.000
E10.2 With renal complications	0.024	0.976	0.000
I35 Nonrheumatic aortic valve disorders	0.000	0.976	0.024
E10.5 With peripheral circulatory complications	0.023	0.977	0.000
T40.5 Cocaine	0.023	0.977	0.000
T36.4 Tetracyclines	0.023	0.977	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.023	0.977	0.000
T40.3 Methadone	0.023	0.977	0.000
T48.5 Anti-common-cold drugs	0.023	0.977	0.000
T36.9 Systemic antibiotic, unspecified	0.022	0.977	0.000
T36.8 Other systemic antibiotics	0.022	0.977	0.000
T36.7 Antifungal antibiotics, systemically used	0.022	0.977	0.000
T36.6 Rifamycins	0.022	0.977	0.000
T36.5 Aminoglycosides	0.022	0.977	0.000
T36.2 Chloramphenicol group	0.022	0.977	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.022	0.977	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.022	0.977	0.000
T40.8 Lysergide [LSD]	0.022	0.977	0.000
T40.7 Cannabis (derivatives)	0.022	0.977	0.000
T40.1 Heroin	0.022	0.977	0.000
T40.0 Opium	0.022	0.977	0.000
K73.9 Chronic hepatitis, unspecified	0.000	0.978	0.022
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.978	0.022
K75 Other inflammatory liver diseases	0.000	0.978	0.022
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.978	0.022
I35.9 Aortic valve disorder, unspecified	0.000	0.978	0.022
I35.0 Aortic (valve) stenosis	0.000	0.979	0.021
T36.3 Macrolides	0.021	0.979	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.021	0.979	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.021	0.979	0.000
K71.0 Toxic liver disease with cholestasis	0.000	0.979	0.021
B34.3 Parvovirus infection, unspecified	0.000	0.979	0.021
B34.2 Coronavirus infection, unspecified	0.000	0.979	0.021
B34.0 Adenovirus infection, unspecified	0.000	0.979	0.021
T40.2 Other opioids	0.021	0.979	0.000
K70 Alcoholic liver disease	0.000	0.979	0.021
T42.3 Barbiturates	0.021	0.979	0.000
E10.8 With unspecified complications	0.021	0.979	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.021	0.979	0.000
E10.0 With coma	0.021	0.979	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.020	0.980	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.020	0.980	0.000
T42.2 Succinimides and oxazolidinediones	0.020	0.980	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.980	0.020
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.020	0.980	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.020	0.980	0.000
T46.7 Peripheral vasodilators	0.020	0.980	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.020	0.980	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.980	0.020
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.980	0.020
I20.8 Other forms of angina pectoris	0.000	0.980	0.020
E10.7 With multiple complications	0.020	0.980	0.000
T45.0 Antiallergic and antiemetic drugs	0.020	0.980	0.000
K71.8 Toxic liver disease with other disorders of liver	0.000	0.980	0.020
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.980	0.020
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.980	0.020
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.980	0.020
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.980	0.020
K71.2 Toxic liver disease with acute hepatitis	0.000	0.980	0.020
E10.6 With other specified complications	0.019	0.980	0.000
T46.1 Calcium-channel blockers	0.019	0.980	0.000
B34.1 Enterovirus infection, unspecified	0.000	0.981	0.019
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.019	0.981	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.981	0.019
T36.0 Penicillins	0.018	0.981	0.000
K75.0 Abscess of liver	0.000	0.981	0.018
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.018	0.982	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.018	0.982	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.982	0.018
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.982	0.018
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.982	0.018
T42.4 Benzodiazepines	0.018	0.982	0.000
I35.1 Aortic (valve) insufficiency	0.000	0.982	0.018
T46.5 Other antihypertensive drugs, not elsewhere classified	0.017	0.983	0.000
I50 Heart failure	0.000	0.983	0.017
T42.0 Hydantoin derivatives	0.017	0.983	0.000
E10.9 Without complications	0.017	0.983	0.000
K71.9 Toxic liver disease, unspecified	0.000	0.984	0.016
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.984	0.016
K70.3 Alcoholic cirrhosis of liver	0.000	0.984	0.016
K75.2 Nonspecific reactive hepatitis	0.000	0.984	0.016
K75.1 Phlebitis of portal vein	0.000	0.984	0.016
I20.9 Angina pectoris, unspecified	0.000	0.984	0.016
T40.4 Other synthetic narcotics	0.015	0.985	0.000
I50.0 Congestive heart failure	0.000	0.985	0.015
E10.1 With ketoacidosis	0.015	0.985	0.000
K70.9 Alcoholic liver disease, unspecified	0.000	0.985	0.015
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.014	0.985	0.000
K70.4 Alcoholic hepatic failure	0.000	0.985	0.015
K75.9 Inflammatory liver disease, unspecified	0.000	0.986	0.014
K70.0 Alcoholic fatty liver	0.000	0.986	0.014
K72 Hepatic failure, not elsewhere classified	0.000	0.986	0.013
T39.1 4-Aminophenol derivatives	0.013	0.987	0.000
I35.8 Other aortic valve disorders	0.000	0.987	0.013
B25-B34 Other viral diseases	0.000	0.987	0.013
K75.8 Other specified inflammatory liver diseases	0.000	0.988	0.012
K74 Fibrosis and cirrhosis of liver	0.000	0.988	0.012
B27 Infectious mononucleosis	0.000	0.988	0.012
B27.9 Infectious mononucleosis, unspecified	0.000	0.989	0.011
K70.1 Alcoholic hepatitis	0.000	0.989	0.011
I20.1 Angina pectoris with documented spasm	0.000	0.990	0.010
K75.4 Autoimmune hepatitis	0.000	0.991	0.009
B30 Viral conjunctivitis	0.000	0.991	0.009
B26 Mumps	0.000	0.991	0.009
K74.5 Biliary cirrhosis, unspecified	0.000	0.991	0.009
K72.0 Acute and subacute hepatic failure	0.000	0.991	0.009
K74.4 Secondary biliary cirrhosis	0.000	0.991	0.009
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.991	0.009
K74.1 Hepatic sclerosis	0.000	0.991	0.009
B27.0 Gammaherpesviral mononucleosis	0.000	0.991	0.009
B27.8 Other infectious mononucleosis	0.000	0.991	0.009
B27.1 Cytomegaloviral mononucleosis	0.000	0.991	0.009
B33 Other viral diseases, not elsewhere classified	0.000	0.992	0.008
K72.1 Chronic hepatic failure	0.000	0.992	0.008
F52.2 Failure of genital response	0.008	0.992	0.000
K74.0 Hepatic fibrosis	0.000	0.993	0.007
B26.9 Mumps without complication	0.000	0.993	0.007
B26.8 Mumps with other complications	0.000	0.993	0.007
B26.3 Mumps pancreatitis	0.000	0.993	0.007
B26.2 Mumps encephalitis	0.000	0.993	0.007
B26.1 Mumps meningitis	0.000	0.993	0.007
B26.0 Mumps orchitis	0.000	0.993	0.007
B30.9 Viral conjunctivitis, unspecified	0.000	0.993	0.007
B30.8 Other viral conjunctivitis	0.000	0.993	0.007
B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)	0.000	0.993	0.007
B30.2 Viral pharyngoconjunctivitis	0.000	0.993	0.007
B30.1 Conjunctivitis due to adenovirus	0.000	0.993	0.007
B30.0 Keratoconjunctivitis due to adenovirus	0.000	0.993	0.007
K74.6 Other and unspecified cirrhosis of liver	0.000	0.993	0.007
I20.0 Unstable angina	0.000	0.993	0.007
E28.2 Polycystic ovarian syndrome	0.000	0.993	0.007
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.000	0.993	0.007
B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]	0.000	0.994	0.006
B33.3 Retrovirus infections, not elsewhere classified	0.000	0.994	0.006
B33.1 Ross River disease	0.000	0.994	0.006
B33.0 Epidemic myalgia	0.000	0.994	0.006
J15.2 Pneumonia due to staphylococcus	0.000	0.994	0.006
D25.9 Leiomyoma of uterus, unspecified	0.000	0.994	0.006
Z48.8 Other specified surgical follow-up care	0.000	0.994	0.006
J15 Bacterial pneumonia, not elsewhere classified	0.000	0.994	0.006
B33.8 Other specified viral diseases	0.000	0.994	0.006
B33.2 Viral carditis	0.000	0.994	0.006
J15.9 Bacterial pneumonia, unspecified	0.000	0.994	0.006
J15.6 Pneumonia due to other aerobic Gram-negative bacteria	0.000	0.995	0.005
C44.5 Skin of trunk	0.005	0.995	0.000
B25 Cytomegaloviral disease	0.000	0.995	0.005
J15.1 Pneumonia due to Pseudomonas	0.000	0.995	0.005
Z95.1 Presence of aortocoronary bypass graft	0.000	0.995	0.005
Z89.5 Acquired absence of leg at or below knee	0.005	0.995	0.000
J15.8 Other bacterial pneumonia	0.000	0.995	0.005
K72.9 Hepatic failure, unspecified	0.000	0.995	0.005
J15.5 Pneumonia due to Escherichia coli	0.000	0.995	0.005
I31.9 Disease of pericardium, unspecified	0.000	0.995	0.005
J15.3 Pneumonia due to streptococcus, group B	0.000	0.995	0.004
Z82.4 Family history of ischaemic heart disease and other diseases of the circulatory system	0.000	0.995	0.005
Z89 Acquired absence of limb	0.004	0.996	0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.000	0.996	0.004
Z89.0 Acquired absence of finger(s) [including thumb], unilateral	0.004	0.996	0.000
B25.2 Cytomegaloviral pancreatitis	0.000	0.996	0.004
B25.1 Cytomegaloviral hepatitis	0.000	0.996	0.004
Z89.6 Acquired absence of leg above knee	0.004	0.996	0.000
R45.8 Other symptoms and signs involving emotional state	0.004	0.996	0.000
J15.4 Pneumonia due to other streptococci	0.000	0.996	0.004
K74.3 Primary biliary cirrhosis	0.000	0.996	0.004
Z89.9 Acquired absence of limb, unspecified	0.004	0.996	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.004	0.996	0.000
I78.1 Naevus, nonneoplastic	0.000	0.996	0.004
Q23.1 Congenital insufficiency of aortic valve	0.004	0.996	0.000
Q23 Congenital malformations of aortic and mitral valves	0.004	0.996	0.000
Q23.0 Congenital stenosis of aortic valve	0.004	0.996	0.000
J15.0 Pneumonia due to Klebsiella pneumoniae	0.000	0.996	0.004
Z89.7 Acquired absence of both lower limbs [any level, except toes alone]	0.004	0.996	0.000
B25.0 Cytomegaloviral pneumonitis	0.001	0.996	0.003
Z89.8 Acquired absence of upper and lower limbs [any level]	0.003	0.996	0.000
Q23.3 Congenital mitral insufficiency	0.003	0.997	0.000
Z89.3 Acquired absence of both upper limbs [any level]	0.003	0.997	0.000
Z89.1 Acquired absence of hand and wrist	0.003	0.997	0.000
I42.6 Alcoholic cardiomyopathy	0.000	0.997	0.003
B25.8 Other cytomegaloviral diseases	0.001	0.997	0.003
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.000	0.997	0.003
B25.9 Cytomegaloviral disease, unspecified	0.000	0.997	0.003
Q27 Other congenital malformations of peripheral vascular system	0.003	0.997	0.000
Y65.8 Other specified misadventures during surgical and medical care	0.003	0.997	0.000
Q27.3 Peripheral arteriovenous malformation	0.003	0.997	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.003	0.997	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.003	0.997	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.003	0.997	0.000
F52.7 Excessive sexual drive	0.003	0.997	0.000
F52.6 Nonorganic dyspareunia	0.003	0.997	0.000
F52.5 Nonorganic vaginismus	0.003	0.997	0.000
F52.4 Premature ejaculation	0.003	0.997	0.000
F52.3 Orgasmic dysfunction	0.003	0.997	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.003	0.997	0.000
Z89.2 Acquired absence of upper limb above wrist	0.003	0.997	0.000
O61.0 Failed medical induction of labour	0.003	0.997	0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.003	0.997	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.003	0.997	0.000
Q23.4 Hypoplastic left heart syndrome	0.003	0.997	0.000
Q23.2 Congenital mitral stenosis	0.003	0.997	0.000
M54.57 Low back pain (Lumbosacral region)	0.003	0.997	0.000
N76.0 Acute vaginitis	0.000	0.997	0.003
F52.0 Lack or loss of sexual desire	0.003	0.997	0.000
L43.9 Lichen planus, unspecified	0.003	0.997	0.000
H26.2 Complicated cataract	0.000	0.997	0.003
Q20-Q28 Congenital malformations of the circulatory system	0.003	0.997	0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.003	0.997	0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.000	0.997	0.003
I50.9 Heart failure, unspecified	0.000	0.997	0.003
W50.9 Unspecified place	0.003	0.997	0.000
M46.9 Inflammatory spondylopathy, unspecified	0.000	0.997	0.003
Q27.4 Congenital phlebectasia	0.002	0.997	0.000
Q27.2 Other congenital malformations of renal artery	0.002	0.997	0.000
Q27.1 Congenital renal artery stenosis	0.002	0.997	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.002	0.997	0.000
I31 Other diseases of pericardium	0.000	0.997	0.003
A41.0 Septicaemia due to Staphylococcus aureus	0.000	0.997	0.003
L60.0 Ingrowing nail	0.000	0.997	0.003
Q28 Other congenital malformations of circulatory system	0.003	0.997	0.000
Z89.4 Acquired absence of foot and ankle	0.002	0.997	0.000
E28 Ovarian dysfunction	0.000	0.997	0.002
Q25 Congenital malformations of great arteries	0.002	0.997	0.000
N94.3 Premenstrual tension syndrome	0.000	0.998	0.002
L60.2 Onychogryphosis	0.000	0.998	0.002
L43.8 Other lichen planus	0.002	0.998	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.002	0.998	0.000
M70.22 Olecranon bursitis-Upper arm	0.000	0.998	0.002
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.002	0.998	0.000
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.000	0.998	0.002
I98.2 Oesophageal varices in diseases classified elsewhere	0.000	0.998	0.002
W60.0 Home	0.002	0.998	0.000
E10-E14 Diabetes mellitus	0.002	0.998	0.000
Q25.0 Patent ductus arteriosus	0.002	0.998	0.000
L43 Lichen planus	0.002	0.998	0.000
Q26 Congenital malformations of great veins	0.002	0.998	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.002	0.998	0.000
C53.0 Endocervix	0.000	0.998	0.002
N71.9 Inflammatory disease of uterus, unspecified	0.002	0.998	0.000
Q25.4 Other congenital malformations of aorta	0.002	0.998	0.000
H52.1 Myopia	0.000	0.998	0.002
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.000	0.998	0.002
H26.4 After-cataract	0.000	0.998	0.002
Q25.3 Stenosis of aorta	0.002	0.998	0.000
W50.8 Other specified place	0.002	0.998	0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.000	0.998	0.002
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.000	0.998	0.002
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.000	0.998	0.002
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.000	0.998	0.002
I31.8 Other specified diseases of pericardium	0.000	0.998	0.002
I31.2 Haemopericardium, not elsewhere classified	0.000	0.998	0.002
Y65 Other misadventures during surgical and medical care	0.002	0.998	0.000
Q24 Other congenital malformations of heart	0.002	0.998	0.000
W60 Contact with plant thorns and spines and sharp leaves	0.002	0.998	0.000
I31.0 Chronic adhesive pericarditis	0.000	0.998	0.002
M93.9 Osteochondropathy, unspecified	0.002	0.998	0.000
I30-I52 Other forms of heart disease	0.000	0.998	0.002
G37.9 Demyelinating disease of central nervous system, unspecified	0.002	0.998	0.000
Q28.9 Congenital malformation of circulatory system, unspecified	0.002	0.998	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.002	0.998	0.000
Q28.1 Other malformations of precerebral vessels	0.002	0.998	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.002	0.998	0.000
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.998	0.002
E28.9 Ovarian dysfunction, unspecified	0.000	0.998	0.002
E28.8 Other ovarian dysfunction	0.000	0.998	0.002
E28.1 Androgen excess	0.000	0.998	0.002
E28.0 Oestrogen excess	0.000	0.998	0.002
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.998	0.002
Q25.9 Congenital malformation of great arteries, unspecified	0.002	0.998	0.000
Q25.8 Other congenital malformations of great arteries	0.002	0.998	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.002	0.998	0.000
Q25.5 Atresia of pulmonary artery	0.002	0.998	0.000
Q25.2 Atresia of aorta	0.002	0.998	0.000
U89.8 Agent resistant to other single specified antibiotic	0.000	0.998	0.002
Q24.0 Dextrocardia	0.002	0.998	0.000
W50.0 Home	0.002	0.998	0.000
C44.6 Skin of upper limb, including shoulder	0.000	0.998	0.002
I31.1 Chronic constrictive pericarditis	0.000	0.998	0.002
W50.4 Street and highway	0.002	0.998	0.000
W50.2 School, other institution and public administrative area	0.002	0.998	0.000
I78 Diseases of capillaries	0.000	0.998	0.002
L43.0 Hypertrophic lichen planus	0.002	0.998	0.000
L60.3 Nail dystrophy	0.000	0.998	0.002
W50.3 Sports and athletics area	0.002	0.998	0.000
W50.7 Farm	0.002	0.998	0.000
W50.6 Industrial and construction area	0.002	0.998	0.000
W50.5 Trade and service area	0.002	0.998	0.000
W50.1 Residential institution	0.002	0.998	0.000
I42 Cardiomyopathy	0.000	0.998	0.002
W60.9 Unspecified place	0.002	0.998	0.000
L60 Nail disorders	0.000	0.998	0.002
Q24.6 Congenital heart block	0.002	0.998	0.000
Q25.6 Stenosis of pulmonary artery	0.002	0.998	0.000
Q65.8 Other congenital deformities of hip	0.002	0.998	0.000
Q24.4 Congenital subaortic stenosis	0.002	0.998	0.000
Q28.3 Other malformations of cerebral vessels	0.002	0.998	0.000
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.998	0.002
E12 Malnutrition-related diabetes mellitus	0.002	0.998	0.000
S42.10 Fracture of scapula (closed)	0.000	0.998	0.002
L43.3 Subacute (active) lichen planus	0.002	0.998	0.000
L43.2 Lichenoid drug reaction	0.002	0.998	0.000
L43.1 Bullous lichen planus	0.002	0.998	0.000
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.002	0.998	0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
Q20.6 Isomerism of atrial appendages	0.002	0.998	0.000
Q20.5 Discordant atrioventricular connexion	0.002	0.998	0.000
Q20.4 Double inlet ventricle	0.002	0.998	0.000
Q20.3 Discordant ventriculoarterial connexion	0.002	0.998	0.000
Q20.2 Double outlet left ventricle	0.002	0.998	0.000
Q20.1 Double outlet right ventricle	0.002	0.998	0.000
Q20.0 Common arterial trunk	0.002	0.998	0.000
Q26.9 Congenital malformation of great vein, unspecified	0.002	0.998	0.000
Q26.8 Other congenital malformations of great veins	0.002	0.998	0.000
Q26.6 Portal vein-hepatic artery fistula	0.002	0.998	0.000
Q26.5 Anomalous portal venous connexion	0.002	0.998	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.002	0.998	0.000
Q26.3 Partial anomalous pulmonary venous connexion	0.002	0.998	0.000
Q26.2 Total anomalous pulmonary venous connexion	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations